Researchers discover new Alzheimer's gene
Date: 2009-08-06
Contact: Jennifer Fitzenberger
Phone: (949) 824-3969
Email: jfitzen@uci.edu
 Steven Potkin
A new study by Dr. Steven Potkin reports that a gene called TOMM40 appears twice as often in people with Alzheimer's disease than in those without it.

IRVINE -- A UC Irvine study has found that a gene called TOMM40 appears twice as often in people with Alzheimer's disease than in those without it. Alzheimer's, for which there is no cure, is the leading cause of elderly dementia.

Having the harmful form of TOMM40 significantly increases one's susceptibility when other risk factors, such as having a gene called ApoE-4, are present, the new study reports. People who have ApoE-4 are three to eight times more likely to develop Alzheimer's.

"The TOMM40 gene influences the ease with which molecules can get in and out of mitochondria, the energy production center and stress mediator of cells. TOMM40 also processes materials that form amyloid plaque, a hallmark of Alzheimer's," said Dr. Steven Potkin, lead author of the study and UC Irvine psychiatry & human behavior professor. "With aging, the number and function of mitochondria decrease, accompanied by a parallel increased risk of developing Alzheimer's. This study points to the use of mitochondrial-based therapies for treating the disease."

The study will be published Aug. 7 in the journal PLoS One.

Supporting the UC Irvine discovery is research presented recently at the International Conference on Alzheimer's Disease in Austria. Duke University scientists found that patients with TOMM40 developed Alzheimer's an average of seven years earlier than those without the gene.

In addition to Potkin, who is also the Robert R. Sprague Chair in Brain Imaging and director of UC Irvine's Brain Imaging Center, UC Irvine scientists Dr. Fabio Macciardi, Guia Guffanti, Dr. Anita Lakatos, Jessica Turner, Dr. Frithjof Kruggel and James Fallon worked on this study. They collaborated with Andrew Saykin of Indiana University, Dr. Michael Weiner of UC San Francisco and Alzheimer's Disease Neuroimaging Initiative patients and investigators.

The study was funded by the National Institute of Biomedical Imaging and Bioengineering, the National Institute on Aging, the National Center for Research Resources and an anonymous foundation.

Founded in 1965, the University of California, Irvine is a top-ranked university dedicated to research, scholarship and community service. Led by Chancellor Michael Drake since 2005, UC Irvine is among the fastest-growing University of California campuses, with more than 27,000 undergraduate and graduate students, 1,100 faculty and 9,200 staff. The top employer in dynamic Orange County, UC Irvine contributes an annual economic impact of $4.2 billion. For more news, visit www.today.uci.edu.